By Sheeba M. | Weedstock Market Intelligence | Monday, September 28, 2026 — 7:00 PM ET
The cannabis sector closed Monday’s session with notable institutional conviction as the DEA Final-4 countdown — four trading days to the October catalyst window — continued to drive accumulation across the major multi-state operators (MSOs) and licensed producers (LPs). End-of-day tape reads confirmed that smart money is positioning ahead of what could be the most consequential regulatory event in U.S. cannabis history.
Monday Close: Key Movers and Volume Summary
Curaleaf Holdings (CURLF) and Green Thumb Industries (GTBIF) led MSO close strength, with both names printing above Friday’s close on above-average volume. Verano Holdings (VRNOF) also held gains into the final 30 minutes, a constructive signal given that late-day weakness has been a recurring pattern during prior consolidation phases. The MJ ETF closed with a +1.4% session gain, marking the third consecutive green Monday — a streak not seen since the sector’s Q1 2024 run.
Canadian LPs CGC (Canopy Growth) and TLRY (Tilray Brands) underperformed domestic MSOs on Monday but remain on watch as cross-border scheduling arbitrage narratives re-emerge heading into October. Any DEA final-rule language touching international harmonization would disproportionately benefit LP balance sheets currently weighed down by U.S. market exclusion.
After-Hours Watch: Regulatory Feeds and Macro Overlay
After-hours cannabis sector monitors should track three vectors tonight:
- Federal Register notifications: Any late-Monday DEA administrative filings could shift the Final-4 timeline. Historically, agency postings have landed between 4:00–6:00 PM ET on weekdays ahead of public-comment windows.
- Macro rate environment: The 10-year Treasury yield closed below 4.20% today — a favorable backdrop for speculative growth sectors including cannabis. Any overnight Fed commentary reinforcing a pause posture supports the bull case through October.
- State-level revenue data: Illinois Q3 adult-use cannabis revenue figures are expected this week. GTBIF’s Illinois concentration (~38% of retail footprint) makes this a direct catalyst. Strong state numbers would validate the Q3 earnings setup articulated in today’s midday analysis.
Tuesday Pre-Market Setup: What to Watch
Heading into Tuesday, September 29, cannabis investors should anchor on the following:
- DEA Final-3 Countdown: The October catalyst window tightens further. Any pre-market news-wire hits referencing DEA rescheduling, Schedule III final rule, or 280E tax reform will drive outsized gap-up opens. Set alerts on Reuters Cannabis, MJBizDaily, and the Federal Register RSS feed.
- CURLF technical level: CURLF has a key resistance level at $1.85 OTC. A clean break with volume above that level Tuesday morning would be a breakout trigger with a measured move toward $2.10–$2.20 over the subsequent 3–5 sessions.
- GTBIF earnings proximity: Green Thumb’s Q3 2026 earnings window opens in approximately 3 weeks. Pre-earnings institutional accumulation typically begins 15–20 trading days out. Tuesday marks day 14 of that window — watch for block trades on GTBIF in the first 90 minutes of trading.
- OGI (OrganiGram Holdings): Canadian LP OGI reports a minor operational update Tuesday morning. While not a major catalyst, any commentary touching U.S. market entry strategy post-DEA rescheduling could move the stock and provide read-through for the broader LP cohort.
280E Tax Exposure: The Numbers That Matter
One of the most underappreciated near-term catalysts in the cannabis sector remains 280E tax code relief. Under Schedule III reclassification, MSOs would no longer be subject to 280E’s prohibition on standard business deductions — a change that would immediately improve effective tax rates from the current punitive 70–80% range to a normalized 25–30% corporate rate.
For GTBIF, which generated approximately $1.1B in revenue in 2025 while paying an effective federal tax rate exceeding 72% due to 280E, Schedule III relief could add $80–100M in annual after-tax cash flow. At current enterprise valuations, that incremental cash generation would represent a material re-rating event. Institutions that have been modeling this scenario since the DEA’s May 2024 proposal are now entering final-position sizing ahead of the October window.
Forward-Looking Analysis: October Catalyst Matrix
The convergence of catalysts entering October 2026 creates a risk/reward environment that sector veterans describe as “asymmetric long.” The three core scenarios and their market implications:
- Base Case (55% probability): DEA issues final Schedule III rule in the first week of October. MSOs gap 15–25% on volume, LPs 10–18%. The sector sustains gains over 30–60 days as institutional re-rating begins, earnings estimates are revised upward, and 280E tax relief gets priced in across DCF models.
- Bull Case (25% probability): Final rule arrives with language explicitly addressing 280E immediately (rather than requiring Congressional action). This scenario drives a sector-wide re-rating event: CURLF, GTBIF, and VRNOF could see 40–60% moves in 2–3 sessions. LPs benefit asymmetrically as U.S. market access becomes plausible within 18–24 months.
- Bear Case (20% probability): Administrative delay or legal challenge to the rescheduling process pushes the final rule into Q1 2027. Near-term giveback of recent gains (10–15% sector pullback), but fundamental thesis intact for patient capital.
Under all three scenarios, the risk/reward for cannabis equities entering October 2026 skews positive over a 90-day horizon. The institutional positioning data from Monday’s close confirms that the market is pricing the base case with optionality on the bull case.
Sheeba’s End-of-Day Take
Monday’s close was a quiet confirmation session — the kind that matters more than a flashy breakout day. Volume was steady, not spectacular. Breadth was positive but not euphoric. That’s exactly the institutional fingerprint of smart-money accumulation in the final days before a binary event. They’re not chasing. They’re loading.
The DEA Final-4 countdown is real. The 280E math is real. The October catalyst window is real. What’s not certain is timing — and in my experience, the market never gives you the clean entry you’re waiting for. The cleanest risk management here is position sizing, not timing. Small enough to hold through volatility. Large enough to matter if the bull case lands.
See you in the Tuesday pre-market. 🌿
Weedstock Market Intelligence provides cannabis sector analysis for informational purposes only. This content does not constitute investment advice. Cannabis investments carry significant risk including total loss of capital. Always conduct your own due diligence.